{"id":"W4414853071","doi":"10.51731/cjht.2025.1249","title":"Cabozantinib","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Cabozantinib; Drug; Compassionate Use; Drug approval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000590972,0.0003065314,0.0005043472,0.0008904634,0.0002775608,0.0007581608,0.0003791667,0.0004293871,0.01019969],"category_scores_gemma":[0.001690064,0.00007747528,0.000650451,0.0009909756,0.0001744823,0.0003822026,0.0001921161,0.0007302598,0.001750781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002397794,"about_ca_system_score_gemma":0.002997827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03040878,"about_ca_topic_score_gemma":0.1030996,"domain_scores_codex":[0.9994965,0.0001078613,0.00006747868,0.00004940326,0.0002296844,0.00004904381],"domain_scores_gemma":[0.9993796,0.0001420078,0.0001439101,0.00001696295,0.0002652268,0.00005224848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009463871,0.00004994165,0.0006772244,0.009790109,0.0003426058,0.0001726379,0.00003669965,0.0001629807,0.001493325,0.002841429,0.1116335,0.8718532],"study_design_scores_gemma":[0.0004505331,0.0002444822,0.003803469,0.00481394,0.0005403546,0.0008026574,0.00003547978,0.00007560224,0.0008195312,0.0005916291,0.9878088,0.00001348501],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.003374194,0.9464951,0.000399631,0.004330878,0.0006399173,0.000100267,0.001842584,0.0000728657,0.04274446],"genre_scores_gemma":[0.06387504,0.9035845,0.001742147,0.004847836,0.0006539724,0.0001260139,0.002949781,0.00002044346,0.02220025],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03040878,"threshold_uncertainty_score":0.06046355,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02085405706881028,"score_gpt":0.3120651900552268,"score_spread":0.2912111329864165,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}